Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Impax Laboratories, LLCc20764exv99w1.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 2, 2011
Impax Laboratories, Inc.
(Exact name of registrant as specified in its charter)
         
Delaware   001-34263   65-0403311
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     
30831 Huntwood Avenue,
Hayward, CA
   
94544
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (510) 240-6000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Item 2.02 Results of Operations and Financial Condition.
On August 2, 2011, Impax Laboratories, Inc. issued a press release announcing its results for the quarter ended June 30, 2011. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibit is furnished herewith.
         
Exhibit No.   Description
  99.1    
Press release issued August 2, 2011.

 

1


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Dated: August 2, 2011   IMPAX LABORATORIES, INC.
 
 
  By:   /s/ Arthur A. Koch, Jr.    
    Name:   Arthur A. Koch, Jr.   
    Title:   Executive Vice President, Finance, and Chief Financial Officer   

 

2


 

         
EXHIBIT INDEX
         
Exhibit No.   Description
  99.1    
Press release issued August 2, 2011.

 

3